C

Codexis
D

CDXS

2.29000
USD
-0.06
(-2.35%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
189,714,704
أصول ذات صلة
GSK
GSK
-0.595
(-1.54%)
38.045 USD
MRK
MRK
-0.180
(-0.23%)
79.110 USD
PFE
PFE
0.085
(0.36%)
23.970 USD
S
SRRK
-2.270
(-6.25%)
34.060 USD
S
SYBX
0.10000
(8.70%)
1.25000 USD
VRTX
VRTX
-7.64
(-1.70%)
440.97 USD
المزيد
الأخبار المقالات

العنوان: Codexis

القطاع: Healthcare
الصناعة: Biotechnology
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.